Navigation Links
General Anesthesia Does Not Boost Cancer Risk, Study Finds
Date:10/3/2011

MONDAY, Oct. 3 (HealthDay News) -- Among patients given general anesthesia for surgery, the length or depth of sedation was not linked to an increased risk of developing cancer within five years of the operation, Swedish researchers report.

"Neither duration of anesthesia nor increased cumulative time with profound sevoflurane anesthesia was associated with an increased risk for new malignant disease within five years after surgery in previously cancer-free patients," study author Maj-Lis Lindholm, of the Karolinska Institute in Stockholm, concluded in a news release from the International Anesthesia Research Society.

In conducting the study, researchers looked at data on almost 3,000 cancer-free Swedish surgical patients who were given sevoflurane -- one of the most widely used inhaled anesthetics. The news release said other studies have raised the theory that anesthesia might reduce immune responses during surgery.

Following up on the patients five years after surgery, the researchers found that 4.3 percent had developed cancer. After taking other factors into consideration, however, the study revealed that there was no link between the duration of anesthesia or the time spent at various depths of sedation with the patient's risk for cancer.

But the researchers pointed out that the rate of cancer among the participants was 37 percent higher than the general population. The findings, they noted in the news release, could not explain this possible increase in cancer risk among patients undergoing surgery.

The study authors also pointed out that the findings do not apply to those having cancer-related surgery or surgeries involving cancer survivors.

The findings were published in the October issue of the journal Anesthesia & Analgesia.

More information

The U.S. National Library of Medicine has more about anesthesia.

-- Mary Elizabeth Dallas

SOURCE: International Anesthesia Research Society, news release, September 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
2. Tyco International to Host 2010 Annual General Meeting of Shareholders
3. AppDynamics Announces General Availability of AppDynamics v2.0
4. Surgeon General with Microsoft HealthVault Expands Consumer Benefits for the My Family Health Portrait Offering
5. RNs Praise Attorney General Move to Subpoena Insurance Plans
6. U.S. Surgeon General Regina Benjamin to Address National Association of Black Journalists Conference on Health Disparities
7. Coffee Is Generally Heart-Friendly
8. General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results
9. United Nations Secretary-General Ban Ki-moon, President Bill Clinton, Launch MASSIVEGOOD, a Citizen Solution for Funding Global Health
10. Delphi Healthcare Parners Announces New General Surgery Hospitalist Program with CarolinaEast Health System in New Bern, North Carolina
11. AdvancedMD Appoints William Stone Vice President and General Manager of Billing Services Partner Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
General Anesthesia Does Not Boost Cancer Risk,  Study Finds
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company dedicated ... met with big-name retail buyers at the January ECRM Trade Show in Hilton Head, ... the utmost safety standards in all of its creations to help create a more ...
(Date:1/21/2017)... ... ... Salveo for life, a company that distributes an effervescent lime-flavored drink called ... part of its presence to expand its market reach. , Using a formula developed ... nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst supporting ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming Home ... and community. “Coming Home 2017” will be held on Friday January 27 ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 Many patients don,t realize that they ... a pharmacy just a few blocks away charges only ... problem Medicationdiscountcard.com has created a price comparison ... much their medication will cost at most nearby pharmacies. ... Medicationdiscountcard.com takes all of the ...
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
Breaking Medicine Technology: